La Razón: Trasplantan a cerdos riñones modificados con organoides humanos
El objetivo es reparar o regenerar un órgano antes del implante para disponer de más que sean viables.
Sarah Moreira
La Vanguardia: Los organoides de riñón producidos en serie abren la vía a mejorar los trasplantes
Los bioingenieros descubren cómo obtener los tejidos de manera rápida y asequible.
EL MUNDO: Prueban con éxito organoides humanos para reparar riñones
Científicos españoles demuestran la viabilidad de una tecnología celular con la que abordar las complicaciones en los trasplantes. El experimento ha demostrado que “la producción es escalable y segura”.
El País: El primer trasplante de minirriñones humanos en cerdos abre una vía para no desperdiciar miles de órganos donados
El avance puede facilitar la recuperación de vísceras dañadas para reducir las listas de espera de trasplantes, que no dejan de crecer
Bioengineering for precision medicine at the 18th IBEC Symposium
The 18th annual IBEC Symposium focused on ‘Bioengineering for Precision Medicine’, which is one of IBEC’s key areas of application. The event was attended by nearly 300 people, including local and international researchers. The multidisciplinary environment provided experts from other centres and the IBEC community with the opportunity to present their projects and exchange knowledge.
IBEC, one of the centres selected by the Pasqual Maragall Foundation for its research grants
Amaya Hernández-Vega, a senior researcher at IBEC, will lead one of the two projects selected in the 2024 call for proposals from the Pasqual Maragall Research Programme, which is dedicated to funding research into Alzheimer’s disease and other neurodegenerative conditions. IBEC also celebrates the participation of Jordi Duran, an associate researcher from the Molecular and Cellular Neurobiotechnology group, who will collaborate on the second selected project.
ARA: Una injecció reverteix símptomesde l’Alzheimer en ratolins
L’administració de nanopartícules permet netejar toxines del cervell
EL PERIÓDICO: Científicos de BCN y China revierten el alzhéimer en ratones
Diseñan una novedosa técnica centrada en restaurar la salud vascular con inyecciones de nanopartículas. «En una hora se han empezado a ver resultados».
Scientists reverse Alzheimer’s in mice using nanoparticles
An international team co-led by the Institute for Bioengineering of Catalonia (IBEC) and the West China Hospital Sichuan University (WCHSU) was able to reverse Alzheimer’s in mice after only 3 injections with nanoparticles. The innovative approach to treating the disease focuses on restoring the normal function of the vasculature, rather than acting on neurons or other brain cells, as has usually been done until now. This achievement, published in the Signal Transduction and Targeted Therapy Journal, is a promising step towards an effective treatment for Alzheimer’s disease.
New York Post: Alzheimer’s breakthrough? Scientists use nanotech to reverse disease in mice
A new study reveals innovative nanotechnology that restored the function of the blood-brain barrier (BBB) to reverse Alzheimer’s in mice.